{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:40:20Z","timestamp":1743388820008,"version":"3.40.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-05785-x","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:13:32Z","timestamp":1743149612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of oral chronic graft-versus-host disease characteristics between patients with malignant and non-malignant hematopoietic disorders"],"prefix":"10.1186","volume":"25","author":[{"given":"Qiaozhi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guocheng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangzhi","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renchuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"3","key":"5785_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.109.913863","volume":"3","author":"DT Kremastinos","year":"2010","unstructured":"Kremastinos DT, Farmakis D, Aessopos A, Hahalis G, Hamodraka E, Tsiapras D, Keren A. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives. Circ Heart Fail. 2010;3(3):451\u20138.","journal-title":"Circ Heart Fail"},{"issue":"29","key":"5785_CR2","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1200\/JCO.20.00150","volume":"38","author":"YJ Chang","year":"2020","unstructured":"Chang YJ, Wu DP, Lai YR, Liu QF, Sun YQ, Hu J, Hu Y, Zhou JF, Li J, Wang SQ, et al. Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label. J Clin Oncol. 2020;38(29):3367\u201376.","journal-title":"J Clin Oncol"},{"issue":"8","key":"5785_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.2174\/1574888X16666210203105340","volume":"16","author":"L Zhai","year":"2021","unstructured":"Zhai L, Liu Y, Huo R, Pan Z, Bin J, Li Z, Tang Q, Fan J. Quality of life in patients with \u03b2-thalassemia major: short-term and long-term effects after haematopoietic stem cell transplantation. Curr Stem Cell Res Ther. 2021;16(8):924\u201330.","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"5785_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbmt.2007.06.017","volume":"14","author":"NS Treister","year":"2008","unstructured":"Treister NS, Cook EF Jr, Antin J, Lee SJ, Soiffer R, Woo SB. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14(1):110\u20135.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"5785_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1601-0825.2008.01448.x","volume":"14","author":"MM Imanguli","year":"2008","unstructured":"Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC. Oral graft-versus-host disease. Oral Dis. 2008;14(5):396\u2013412.","journal-title":"Oral Dis"},{"issue":"4","key":"5785_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/odi.12028","volume":"19","author":"JW Mays","year":"2013","unstructured":"Mays JW, Fassil H, Edwards DA, Pavletic SZ, Bassim CW. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research. Oral Dis. 2013;19(4):327\u201346.","journal-title":"Oral Dis"},{"issue":"6","key":"5785_CR7","first-page":"458","volume":"59","author":"CW Noce","year":"2011","unstructured":"Noce CW, Gomes A, Copello A, Barbosa RD, Sant\u2019anna S, Moreira MC, Correa ME, Maiolino A, Torres SR. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients. Gen Dent. 2011;59(6):458\u201362 quiz 463\u2013454.","journal-title":"Gen Dent"},{"issue":"7 Suppl","key":"5785_CR8","doi-asserted-by":"publisher","first-page":"45S","DOI":"10.1177\/0022034512450881","volume":"91","author":"H Fassil","year":"2012","unstructured":"Fassil H, Bassim CW, Mays J, Edwards D, Baird K, Steinberg SM, Williams KM, Cowen EW, Mitchell SA, Hakim FT, et al. Oral chronic graft-vs.-host disease characterization using the NIH scale. J Dent Res. 2012;91(7 Suppl):45S-51S.","journal-title":"J Dent Res"},{"issue":"3","key":"5785_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transpl. 2015;21(3):389-401 e381.","journal-title":"Biol Blood Marrow Transpl"},{"key":"5785_CR10","doi-asserted-by":"crossref","unstructured":"Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW. Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations. J Am Acad Dermatol. 2024;90(1):1\u201316.","DOI":"10.1016\/j.jaad.2022.12.024"},{"issue":"10","key":"5785_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.oraloncology.2015.07.009","volume":"51","author":"J DePalo","year":"2015","unstructured":"DePalo J, Chai X, Lee SJ, Cutler CS, Treister N. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life. Oral Oncol. 2015;51(10):944\u20139.","journal-title":"Oral Oncol"},{"key":"5785_CR12","doi-asserted-by":"publisher","first-page":"934607","DOI":"10.3389\/froh.2022.934607","volume":"3","author":"M Boor","year":"2022","unstructured":"Boor M, Raber-Durlacher JE, Hazenberg MD, Rozema FR, Laheij A. Taste and smell disturbances in patients with chronic oral graft vs. host disease: an observational study. Front Oral Health. 2022;3:934607.","journal-title":"Front Oral Health"},{"key":"5785_CR13","doi-asserted-by":"publisher","first-page":"104629","DOI":"10.1016\/j.oraloncology.2020.104629","volume":"109","author":"Z Liu","year":"2020","unstructured":"Liu Z, Peng Y, Yong X, Mei G, Yang Y, Yi C, Tao R. A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation. Oral Oncol. 2020;109:104629.","journal-title":"Oral Oncol."},{"key":"5785_CR14","doi-asserted-by":"publisher","first-page":"105399","DOI":"10.1016\/j.oraloncology.2021.105399","volume":"121","author":"T Wu","year":"2021","unstructured":"Wu T, Liu Z, Yong X, Mei G, Jiang Q, Fang M, Li P, Zhang Z, Tao R. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: a case report and literature review. Oral Oncol. 2021;121:105399.","journal-title":"Oral Oncol."},{"key":"5785_CR15","doi-asserted-by":"crossref","unstructured":"Janowiak-Majeranowska A, Osowski J, Mikaszewski B, Majeranowski A. Secondary oral cancer after systemic treatment of hematological malignancies and oral GVHD: a systematic review. Cancers. 2022;14(9):2175.","DOI":"10.3390\/cancers14092175"},{"issue":"1","key":"5785_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00520-020-05681-w","volume":"29","author":"O Bar","year":"2021","unstructured":"Bar O, Elad S, Avni B, Abu-Tair J, Zaharia B, Hanut A, Zadik Y. Oral verruciform xanthoma in chronic graft-versus-host disease patients. Support Care Cancer. 2021;29(1):79\u201384.","journal-title":"Support Care Cancer"},{"key":"5785_CR17","doi-asserted-by":"crossref","unstructured":"Tang X, Fang J, Yu J, Li Z, Chen J, Sun X, Zhu Y, Hu S, Qin M, Tang Y et al. Clinical outcomes of unrelated cord blood transplantation in children with malignant and non\u2010malignant diseases: multicenter experience in China. Pediatr Transpl. 2018;22(1):10.1111\/petr.13090.","DOI":"10.1111\/petr.13090"},{"issue":"11","key":"5785_CR18","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/blood-2010-08-302109","volume":"117","author":"ME Flowers","year":"2011","unstructured":"Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, Pereira SE, Nash RA, Mielcarek M, Fero ML, et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood. 2011;117(11):3214\u20139.","journal-title":"Blood"},{"issue":"10","key":"5785_CR19","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.bbmt.2016.06.020","volume":"22","author":"M Grube","year":"2016","unstructured":"Grube M, Holler E, Weber D, Holler B, Herr W, Wolff D. Risk factors and outcome of chronic graft-versus-host disease after allogeneic stem cell transplantation-results from a single-center observational study. Biol Blood Marrow Transplant. 2016;22(10):1781\u201391.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"5785_CR20","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","volume":"121","author":"Y Inamoto","year":"2013","unstructured":"Inamoto Y, Storer BE, Petersdorf EW, Nelson JL, Lee SJ, Carpenter PA, Sandmaier BM, Hansen JA, Martin PJ, Flowers ME. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease. Blood. 2013;121(25):5098\u2013103.","journal-title":"Blood"},{"issue":"11","key":"5785_CR21","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1007\/s00520-021-06197-7","volume":"29","author":"J Stolze","year":"2021","unstructured":"Stolze J, Boor M, Hazenberg MD, Brand HS, Raber-Durlacher JE, Laheij A. Oral health-related quality of life of patients with oral chronic graft-versus-host disease. Support Care Cancer. 2021;29(11):6353\u201360.","journal-title":"Support Care Cancer"},{"issue":"1","key":"5785_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00520-021-06349-9","volume":"30","author":"AC Scaraficci","year":"2022","unstructured":"Scaraficci AC, Fernandes PM, Abreu Alves F, Filho JS, Jaguar GC. Oral manifestations of graft-versus-host disease in patients submitted to allogeneic hematopoietic stem cell transplantation: the experience of a Brazilian Cancer Center. Support Care Cancer. 2022;30(1):567\u201373.","journal-title":"Support Care Cancer"},{"issue":"5","key":"5785_CR23","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1007\/s00520-022-06836-7","volume":"30","author":"KE Tanem","year":"2022","unstructured":"Tanem KE, Wilberg P, Diep PP, Ruud E, Skaare AB, Brinch L, Herlofson BB. Oral chronic GVHD after allogeneic stem cell transplantation without total body irradiation performed at a young age. Support Care Cancer. 2022;30(5):4121\u20138.","journal-title":"Support Care Cancer"},{"key":"5785_CR24","first-page":"e167","volume":"2023","author":"N Pengpis","year":"2014","unstructured":"Pengpis N, Prueksrisakul T, Chanswangphuwana C. Clinical characteristics of oral chronic graft-versus-host disease according to the National Institutes of Health (USA) consensus criteria. Med Oral Patol Oral Cir Bucal. 2014;2023:e167\u201373.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"4","key":"5785_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s12185-020-03055-w","volume":"113","author":"O Lertkovit","year":"2021","unstructured":"Lertkovit O, Anurathapan U, Hongeng S, Thokanit NS, Pakakasama S. Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation. Int J Hematol. 2021;113(4):556\u201365.","journal-title":"Int J Hematol"},{"issue":"3","key":"5785_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jare.2014.11.001","volume":"6","author":"HK Mahmoud","year":"2015","unstructured":"Mahmoud HK, Elhaddad AM, Fahmy OA, Samra MA, Abdelfattah RM, El-Nahass YH, Fathy GM, Abdelhady MS. Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders. J Adv Res. 2015;6(3):449\u201358.","journal-title":"J Adv Res"},{"issue":"5","key":"5785_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41409-022-01613-w","volume":"57","author":"MA Yesilipek","year":"2022","unstructured":"Yesilipek MA, Uygun V, Kupesiz A, Karasu G, Ozturk G, Ertem M, \u015ea\u015fmaz \u0130, Dalo\u011flu H, G\u00fcler E, Hazar V, et al. Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major. Turkish experience. Bone Marrow Transplant. 2022;57(5):760\u20137.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"5785_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0022034515570942","volume":"94","author":"CW Bassim","year":"2015","unstructured":"Bassim CW, Fassil H, Mays JW, Edwards D, Baird K, Steinberg SM, Cowen EW, Naik H, Datiles M, Stratton P, Gress RE, et al. Oral disease profiles in chronic graft versus host disease. J Dent Res. 2015;94(4):547\u201354.","journal-title":"J Dent Res."},{"key":"5785_CR29","doi-asserted-by":"crossref","unstructured":"Jeppesen H, Gj\u00e6rde LK, Lindegaard J, Julian HO, Heegaard S, Sengel\u00f8v H. Ocular chronic graft-versus-host disease and its relation to other organ manifestations and outcomes after allogeneic hematopoietic cell transplantation. Transplant Cell Ther. 2022;28(12):833.e1\u20137.","DOI":"10.1016\/j.jtct.2022.08.016"},{"issue":"4","key":"5785_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbmt.2019.10.019","volume":"26","author":"BK Hamilton","year":"2020","unstructured":"Hamilton BK, Storer BE, Wood WA, Pidala JA, Cutler CS, Martin PJ, Chen G, Flowers ME, Lee SJ. Disability related to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2020;26(4):772\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"5785_CR31","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00784-011-0529-8","volume":"16","author":"RG Resende","year":"2012","unstructured":"Resende RG, de F\u00e1tima C-S, Ar\u00e3o TC, Brito JA, Bittencourt H, Gomez RS, Abreu MH. Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease. Clin Oral Investig. 2012;16(2):565\u201370.","journal-title":"Clin Oral Investig"},{"issue":"2","key":"5785_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/bmt.2011.63","volume":"47","author":"KM Hull","year":"2012","unstructured":"Hull KM, Kerridge I, Schifter M. Long-term oral complications of allogeneic haematopoietic SCT. Bone Marrow Transplant. 2012;47(2):265\u201370.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"5785_CR33","first-page":"98","volume":"30","author":"MA da Fonseca","year":"2008","unstructured":"da Fonseca MA, Hong C. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation. Pediatr Dent. 2008;30(2):98\u2013104.","journal-title":"Pediatr Dent"},{"issue":"6","key":"5785_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12185-018-2520-5","volume":"108","author":"A Piccin","year":"2018","unstructured":"Piccin A, Tagnin M, Vecchiato C, Al-Khaffaf A, Beqiri L, Kaiser C, Agreiter I, Negri G, Kob M, Di Pierro A, et al. Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective study. Int J Hematol. 2018;108(6):615\u201321.","journal-title":"Int J Hematol"},{"key":"5785_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1600-065X.1997.tb00978.x","volume":"157","author":"E Goulmy","year":"1997","unstructured":"Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev. 1997;157:125\u201340.","journal-title":"Immunol Rev"},{"issue":"11","key":"5785_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.bbmt.2014.06.031","volume":"20","author":"D Ion","year":"2014","unstructured":"Ion D, Stevenson K, Woo SB, Ho VT, Soiffer R, Antin JH, Treister NS. Characterization of oral involvement in acute graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20(11):1717\u201321.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"5785_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12032-018-1127-2","volume":"35","author":"G Afram","year":"2018","unstructured":"Afram G, Simon JAP, Remberger M, Caballero-Velazquez T, Martino R, Pinana JL, Ringden O, Esquirol A, Lopez-Corral L, Garcia I, et al. Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting. Medical oncology (Northwood, London, England). 2018;35(6):79.","journal-title":"Medical oncology (Northwood, London, England)"},{"issue":"2","key":"5785_CR38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3324\/haematol.2015.135699","volume":"101","author":"BN Savani","year":"2016","unstructured":"Savani BN, Labopin M, Blaise D, Niederwieser D, Ciceri F, Ganser A, Arnold R, Afanasyev B, Vigouroux S, Milpied N, et al. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT. Haematologica. 2016;101(2):256\u201362.","journal-title":"Haematologica"},{"issue":"16","key":"5785_CR39","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","volume":"367","author":"C Anasetti","year":"2012","unstructured":"Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med. 2012;367(16):1487\u201396.","journal-title":"N Engl J Med"},{"issue":"10","key":"5785_CR40","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jcyt.2022.05.009","volume":"24","author":"T Jo","year":"2022","unstructured":"Jo T, Arai Y, Kondo T, Mizuno S, Hirabayashi S, Inamoto Y, Doki N, Fukuda T, Ozawa Y, Katayama Y, et al. Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients. Cytotherapy. 2022;24(10):1013\u201325.","journal-title":"Cytotherapy"},{"key":"5785_CR41","doi-asserted-by":"crossref","unstructured":"Picardi A, Miranda M, Liciani F, Paterno G, Arcese W. Bollero P. Identification of oral risk factors for chronic graft versus host disease in haematological patients who underwent allogeneic haematopoietic stem cell transplantation. Oral Implantol (Rome). 2017;10(4):390\u20137.","DOI":"10.11138\/orl\/2017.10.4.390"},{"issue":"2","key":"5785_CR42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00520-011-1116-x","volume":"20","author":"H Kashiwazaki","year":"2012","unstructured":"Kashiwazaki H, Matsushita T, Sugita J, Shigematsu A, Kasashi K, Yamazaki Y, Kanehira T, Yamamoto S, Kondo T, Endo T, et al. Professional oral health care reduces oral mucositis and febrile neutropenia in patients treated with allogeneic bone marrow transplantation. Support Care Cancer. 2012;20(2):367\u201373.","journal-title":"Support Care Cancer"},{"issue":"11","key":"5785_CR43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.adaj.2020.08.001","volume":"151","author":"TM Haverman","year":"2020","unstructured":"Haverman TM, Raber-Durlacher JE, Raghoebar II, Rademacher WMH, Rozema FR, Hazenberg MD, Epstein JB, Treister NS. Oral chronic graft-versus-host disease: What the general dental practitioner needs to know. J Am Dent Assoc. 2020;151(11):846\u201356.","journal-title":"J Am Dent Assoc"},{"issue":"2","key":"5785_CR44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1399-0012.2010.01283.x","volume":"25","author":"PS Santos","year":"2011","unstructured":"Santos PS, Coracin FL, Barros JC, Dulley FL, Nunes FD, Magalhaes MG. Impact of oral care prior to HSCT on the severity and clinical outcomes of oral mucositis. Clin Transplant. 2011;25(2):325\u20138.","journal-title":"Clin Transplant"},{"issue":"17","key":"5785_CR45","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2012-05-393389","volume":"120","author":"N Treister","year":"2012","unstructured":"Treister N, Duncan C, Cutler C, Lehmann L. How we treat oral chronic graft-versus-host disease. Blood. 2012;120(17):3407\u201318.","journal-title":"Blood"},{"issue":"8","key":"5785_CR46","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/odi.13704","volume":"27","author":"S Warnakulasuriya","year":"2021","unstructured":"Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, Gonzalez-Moles MA, Kerr AR, Lodi G, Mello FW, Monteiro L, Ogden GR, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862\u201380.","journal-title":"Oral Dis"},{"issue":"4","key":"5785_CR47","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41409-018-0299-x","volume":"54","author":"CP Chaulagain","year":"2019","unstructured":"Chaulagain CP, Sprague KA, Pilichowska M, Cowan J, Klein AK, Kaul E, Miller KB. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 2019;54(4):560\u20136.","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"5785_CR48","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41409-020-01147-z","volume":"56","author":"S Santarone","year":"2021","unstructured":"Santarone S, Natale A, Angelini S, Papalinetti G, Vaddinelli D, Di Bartolomeo A, Di Bartolomeo P. Secondary oral cancer following hematopoietic cell transplantation. Bone Marrow Transplant. 2021;56(5):1038\u201346.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"5785_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/bmt.2015.63","volume":"50","author":"Y Inamoto","year":"2015","unstructured":"Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, et al. Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant. 2015;50(8):1013\u201323.","journal-title":"Bone Marrow Transplant"},{"key":"5785_CR50","doi-asserted-by":"crossref","unstructured":"Janowiak-Majeranowska A, Osowski J, Mikaszewski B, Majeranowski A. Secondary Oral Cancer after Systemic Treatment of Hematological Malignancies and Oral GVHD: A Systematic Review. Cancers (Basel). 2022;14(9):2175.\u00a0","DOI":"10.3390\/cancers14092175"},{"issue":"2","key":"5785_CR51","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/annonc\/mdt558","volume":"25","author":"Y Atsuta","year":"2014","unstructured":"Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, et al. Continuing increased risk of oral\/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014;25(2):435\u201341.","journal-title":"Ann Oncol"},{"key":"5785_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.903154","volume":"3","author":"D Dean","year":"2022","unstructured":"Dean D, Sroussi H. Oral Chronic Graft-Versus-Host Disease. Front Oral Health. 2022;3: 903154.","journal-title":"Front Oral Health"},{"issue":"1","key":"5785_CR53","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1182\/blood-2010-07-294629","volume":"117","author":"NS Majhail","year":"2011","unstructured":"Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood. 2011;117(1):316\u201322.","journal-title":"Blood"},{"issue":"11","key":"5785_CR54","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1097\/TP.0b013e3181f9caaa","volume":"90","author":"S Elad","year":"2010","unstructured":"Elad S, Zadik Y, Zeevi I, Miyazaki A, de Figueiredo MA, Or R. Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation. 2010;90(11):1243\u20134.","journal-title":"Transplantation"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05785-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-05785-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-05785-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T02:23:58Z","timestamp":1743387838000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-05785-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5785"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-05785-x","relation":{},"ISSN":["1472-6831"],"issn-type":[{"type":"electronic","value":"1472-6831"}],"subject":[],"published":{"date-parts":[[2025,3,28]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the Affiliated Stomatology Hospital of Guangxi Medical University (Approval Number: 2024055). Written informed consent was obtained from all participants for the publication of this study, including all associated data and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written consent for publication was obtained from patients to publish all clinical details and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"449"}}